Syra Health CORP 10-Q quarterly reports

Syra Health Corp. announced a significant shift to profitability in its Q2 2026 report, driven by a 23% year-over-year revenue increase and improved gross margins.

Syra Health reports a return to profitability in Q1 2026 with net income of $240,979, driven by growth in population health services.

Syra Health Corp. reported a reduced net loss for the third quarter and nine months ended September 30, 2025, despite an overall revenue decline and ongoing liquidity concerns.

Syra Health Corp. reported a significant reduction in net loss for Q2 2025, driven by improved gross margins and cost reductions, despite a shift in revenue mix from healthcare workforce to population health services.

Syra Health Corp.'s Q1 2025 results show a slight revenue increase and a significant reduction in net loss compared to the same period last year.

Syra Health Corp. announced a net loss of $417,535 for the third quarter of 2024, an increase from the previous year's loss, despite a 42% rise in net revenues.

Syra Health Corp. reported a net loss of $1.39 million for the second quarter of 2024, compared to a net loss of $802,800 in the same period last year, as the company continues to invest in growth and expansion.

Syra Health Corp. saw a significant increase in revenue during the first quarter of 2024, but also experienced a larger net loss compared to the same period last year.